ENDRA Life Sciences Inc. — Company profile
Healthcare · Diagnostics & Research · United States
Last price 4.75 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 7.12M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source such as radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion analysis. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
Details
| Name | ENDRA Life Sciences Inc. |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Employees | 11 |
| Founded | 2007 |
| Ipo Date | 2017-05-09 |
| Ceo | Alexander Tokman |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US29273B5003 |
| Cusip | 29273B500 |
| Cik | 0001681682 |
| Sic | 3845 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Alexander Y. Tokman | Chief Executive Officer and Chairman |
| Richard Jacroux | Chief Financial Officer and Secretary |
| Dr. Jonathan Behr Ph.D. | Co-Founder |
| Scott Sober | Head of Operations |
| Ziad Rouag J.D. | Head of Regulatory and Clinical Affairs |
| Idan Steinberg | Head of Engineering |
Contact
| Address | 3600 Green Court, Suite 350, Ann Arbor, Michigan 48105-1570, United States |
| Phone | 734 335 0468 |
| Website | https://endrainc.com |